Pyridam Farma Tbk vs Saraswanti Indoland Development Tbk. — how do they compare? Pyridam Farma Tbk trades at Rp214 (market cap 2.31T, 10.47M 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp92 (market cap 490.04B, 1.51M 24h volume). The key difference: Pyridam Farma Tbk is far larger — about 4.7× Saraswanti Indoland Development Tbk.'s market cap, and Pyridam Farma Tbk is more actively traded (10.47M versus 1.51M). Which is the better fit depends on your goals.
| PYFA | SWID | |
|---|---|---|
Market Cap | 2.31T | 490.04B |
Volume | 10.47M | 1.51M |
Lot | 104.73K | 15.14K |
Turnover | 2.2B | 137.63M |
Average Price | 209.71 | 90.94 |
Value | 2.2B | 137.63M |
Indicative Equilibrium Price | 214 | 92 |
Indicative Equilibrium Volume | 10.89K | 1.49K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.
Read more on PYFA →PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Read more on SWID →